Lai et al. reported that PPI reversed resistance in osimertinib-resistant NSCLC cell lines and xenografts by regulating PI3K/AKT signaling and controlling the expression of apoptosis-related proteins. Here, AKT1 is linked to non-small cell lung carcinoma.